25 XP   0   0   10

Sarana Meditama Metropolitan
Buy, Hold or Sell?

Let's analyse Sarana Meditama Metropolitan together

PenkeI guess you are interested in Sarana Meditama Metropolitan. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sarana Meditama Metropolitan. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sarana Meditama Metropolitan

I send you an email if I find something interesting about Sarana Meditama Metropolitan.

Quick analysis of Sarana Meditama Metropolitan (30 sec.)










What can you expect buying and holding a share of Sarana Meditama Metropolitan? (30 sec.)

How much money do you get?

How much money do you get?
Rp0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
Rp211.39
Expected worth in 1 year
Rp22.63
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
Rp-185.00
Return On Investment
-72.3%

For what price can you sell your share?

Current Price per Share
Rp256.00
Expected price per share
Rp242.00 - Rp284.00
How sure are you?
50%

1. Valuation of Sarana Meditama Metropolitan (5 min.)




Live pricePrice per Share (EOD)

Rp256.00

Intrinsic Value Per Share

Rp-79.29 - Rp40.40

Total Value Per Share

Rp132.10 - Rp251.79

2. Growth of Sarana Meditama Metropolitan (5 min.)




Is Sarana Meditama Metropolitan growing?

Current yearPrevious yearGrowGrow %
How rich?$362.2m$443.1m-$80.8m-22.3%

How much money is Sarana Meditama Metropolitan making?

Current yearPrevious yearGrowGrow %
Making money$434.7k$13.8m-$13.4m-3,087.2%
Net Profit Margin0.3%10.9%--

How much money comes from the company's main activities?

3. Financial Health of Sarana Meditama Metropolitan (5 min.)




4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  


Richest
#66 / 187

Most Revenue
#93 / 187

Most Profit
#111 / 187

Most Efficient
#115 / 187

What can you expect buying and holding a share of Sarana Meditama Metropolitan? (5 min.)

Welcome investor! Sarana Meditama Metropolitan's management wants to use your money to grow the business. In return you get a share of Sarana Meditama Metropolitan.

What can you expect buying and holding a share of Sarana Meditama Metropolitan?

First you should know what it really means to hold a share of Sarana Meditama Metropolitan. And how you can make/lose money.

Speculation

The Price per Share of Sarana Meditama Metropolitan is Rp256.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sarana Meditama Metropolitan.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sarana Meditama Metropolitan, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is Rp211.39. Based on the TTM, the Book Value Change Per Share is Rp-47.19 per quarter. Based on the YOY, the Book Value Change Per Share is Rp226.73 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is Rp0.94 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sarana Meditama Metropolitan.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 Rp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per Share
Usd Eps0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.000.0%0.000.0%0.020.0%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.020.0%0.000.0%0.000.0%
Usd Price Per Share0.03-0.03-0.04-0.04-0.13-
Price to Earnings Ratio1,182.71-1,182.71-45.77-265.47-726.70-
Price-to-Total Gains Ratio-6.49--6.49-1.63-0.78-175.81-
Price to Book Ratio1.42-1.42-1.43-4.73-72.80-
Price-to-Total Gains Ratio-6.49--6.49-1.63-0.78-175.81-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0256
Number of shares39062
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (39062 shares)-180.66118.82
Gains per Year (39062 shares)-722.64475.30
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
115-737-7335471465
229-1475-145610941940
344-2212-21791414121415
459-2949-29021918821890
573-3687-36252423532365
688-4424-43482928232840
7103-5161-50713332943315
8118-5899-57943837643790
9132-6636-65174342354265
10147-7373-72404847054740

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%8.02.04.057.1%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%9.05.00.064.3%
Dividend per Share1.00.00.0100.0%1.00.02.033.3%2.00.03.040.0%5.00.05.050.0%5.00.09.035.7%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%9.05.00.064.3%

Fundamentals of Sarana Meditama Metropolitan

About Sarana Meditama Metropolitan

PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk operates as a subsidiary of PT Elang Mahkota Teknologi Tbk.

Fundamental data was last updated by Penke on 2024-04-03 12:14:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Sarana Meditama Metropolitan.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sarana Meditama Metropolitan earns for each Rp1 of revenue.

  • Above 10% is considered healthy but always compare Sarana Meditama Metropolitan to the Medical Care Facilities industry mean.
  • A Net Profit Margin of 0.3% means that Rp0.00 for each Rp1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sarana Meditama Metropolitan:

  • The MRQ is 0.3%. The company is not making a profit/loss.
  • The TTM is 0.3%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ0.3%TTM0.3%0.0%
TTM0.3%YOY10.9%-10.6%
TTM0.3%5Y-18.6%+18.9%
5Y-18.6%10Y-4.2%-14.3%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%2.5%-2.2%
TTM0.3%2.6%-2.3%
YOY10.9%3.8%+7.1%
5Y-18.6%3.3%-21.9%
10Y-4.2%3.7%-7.9%
1.1.2. Return on Assets

Shows how efficient Sarana Meditama Metropolitan is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sarana Meditama Metropolitan to the Medical Care Facilities industry mean.
  • 0.1% Return on Assets means that Sarana Meditama Metropolitan generated Rp0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sarana Meditama Metropolitan:

  • The MRQ is 0.1%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.1%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.1%TTM0.1%0.0%
TTM0.1%YOY2.8%-2.7%
TTM0.1%5Y-4.7%+4.8%
5Y-4.7%10Y1.1%-5.8%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%0.8%-0.7%
TTM0.1%0.7%-0.6%
YOY2.8%1.2%+1.6%
5Y-4.7%1.1%-5.8%
10Y1.1%1.3%-0.2%
1.1.3. Return on Equity

Shows how efficient Sarana Meditama Metropolitan is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sarana Meditama Metropolitan to the Medical Care Facilities industry mean.
  • 0.1% Return on Equity means Sarana Meditama Metropolitan generated Rp0.00 for each Rp1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sarana Meditama Metropolitan:

  • The MRQ is 0.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.1%TTM0.1%0.0%
TTM0.1%YOY3.6%-3.5%
TTM0.1%5Y-17.2%+17.3%
5Y-17.2%10Y-0.4%-16.8%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%2.4%-2.3%
TTM0.1%2.4%-2.3%
YOY3.6%3.0%+0.6%
5Y-17.2%2.7%-19.9%
10Y-0.4%2.8%-3.2%

1.2. Operating Efficiency of Sarana Meditama Metropolitan.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sarana Meditama Metropolitan is operating .

  • Measures how much profit Sarana Meditama Metropolitan makes for each Rp1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sarana Meditama Metropolitan to the Medical Care Facilities industry mean.
  • An Operating Margin of 2.5% means the company generated Rp0.02  for each Rp1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sarana Meditama Metropolitan:

  • The MRQ is 2.5%. The company is operating less efficient.
  • The TTM is 2.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ2.5%TTM2.5%0.0%
TTM2.5%YOY14.9%-12.4%
TTM2.5%5Y6.8%-4.4%
5Y6.8%10Y8.8%-2.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5%6.7%-4.2%
TTM2.5%6.7%-4.2%
YOY14.9%7.4%+7.5%
5Y6.8%6.8%+0.0%
10Y8.8%8.2%+0.6%
1.2.2. Operating Ratio

Measures how efficient Sarana Meditama Metropolitan is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • An Operation Ratio of 1.63 means that the operating costs are Rp1.63 for each Rp1 in net sales.

Let's take a look of the Operating Ratio trends of Sarana Meditama Metropolitan:

  • The MRQ is 1.634. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.634. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.634TTM1.6340.000
TTM1.634YOY1.419+0.215
TTM1.6345Y1.509+0.125
5Y1.50910Y1.240+0.269
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6341.163+0.471
TTM1.6341.112+0.522
YOY1.4191.014+0.405
5Y1.5091.023+0.486
10Y1.2401.004+0.236

1.3. Liquidity of Sarana Meditama Metropolitan.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sarana Meditama Metropolitan is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A Current Ratio of 1.54 means the company has Rp1.54 in assets for each Rp1 in short-term debts.

Let's take a look of the Current Ratio trends of Sarana Meditama Metropolitan:

  • The MRQ is 1.537. The company is able to pay all its short-term debts. +1
  • The TTM is 1.537. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.537TTM1.5370.000
TTM1.537YOY2.594-1.057
TTM1.5375Y1.764-0.227
5Y1.76410Y1.307+0.457
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5371.289+0.248
TTM1.5371.311+0.226
YOY2.5941.405+1.189
5Y1.7641.382+0.382
10Y1.3071.416-0.109
1.3.2. Quick Ratio

Measures if Sarana Meditama Metropolitan is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sarana Meditama Metropolitan to the Medical Care Facilities industry mean.
  • A Quick Ratio of 1.37 means the company can pay off Rp1.37 for each Rp1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sarana Meditama Metropolitan:

  • The MRQ is 1.374. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.374. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.374TTM1.3740.000
TTM1.374YOY2.706-1.332
TTM1.3745Y1.514-0.141
5Y1.51410Y1.212+0.302
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3740.921+0.453
TTM1.3740.950+0.424
YOY2.7061.074+1.632
5Y1.5141.158+0.356
10Y1.2121.146+0.066

1.4. Solvency of Sarana Meditama Metropolitan.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sarana Meditama Metropolitan assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sarana Meditama Metropolitan to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 0.30 means that Sarana Meditama Metropolitan assets are financed with 29.5% credit (debt) and the remaining percentage (100% - 29.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sarana Meditama Metropolitan:

  • The MRQ is 0.295. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.295. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.295TTM0.2950.000
TTM0.295YOY0.104+0.191
TTM0.2955Y0.430-0.135
5Y0.43010Y0.458-0.028
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2950.521-0.226
TTM0.2950.547-0.252
YOY0.1040.516-0.412
5Y0.4300.560-0.130
10Y0.4580.534-0.076
1.4.2. Debt to Equity Ratio

Measures if Sarana Meditama Metropolitan is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sarana Meditama Metropolitan to the Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 41.9% means that company has Rp0.42 debt for each Rp1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sarana Meditama Metropolitan:

  • The MRQ is 0.419. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.419. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.419TTM0.4190.000
TTM0.419YOY0.135+0.284
TTM0.4195Y1.041-0.623
5Y1.04110Y1.046-0.005
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4190.916-0.497
TTM0.4190.952-0.533
YOY0.1351.008-0.873
5Y1.0411.244-0.203
10Y1.0461.253-0.207

2. Market Valuation of Sarana Meditama Metropolitan

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every Rp1 in earnings Sarana Meditama Metropolitan generates.

  • Above 15 is considered overpriced but always compare Sarana Meditama Metropolitan to the Medical Care Facilities industry mean.
  • A PE ratio of 1,182.71 means the investor is paying Rp1,182.71 for every Rp1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sarana Meditama Metropolitan:

  • The EOD is 1,009.247. Based on the earnings, the company is expensive. -2
  • The MRQ is 1,182.712. Based on the earnings, the company is expensive. -2
  • The TTM is 1,182.712. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1,009.247MRQ1,182.712-173.464
MRQ1,182.712TTM1,182.7120.000
TTM1,182.712YOY45.767+1,136.944
TTM1,182.7125Y265.469+917.243
5Y265.46910Y726.696-461.228
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD1,009.24711.438+997.809
MRQ1,182.71210.518+1,172.194
TTM1,182.71214.051+1,168.661
YOY45.76711.500+34.267
5Y265.46916.455+249.014
10Y726.69620.280+706.416
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sarana Meditama Metropolitan:

  • The EOD is -55.329. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -64.838. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -64.838. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-55.329MRQ-64.838+9.510
MRQ-64.838TTM-64.8380.000
TTM-64.838YOY55.286-120.124
TTM-64.8385Y44.898-109.736
5Y44.89810Y-150.689+195.587
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-55.3298.429-63.758
MRQ-64.8387.334-72.172
TTM-64.8387.397-72.235
YOY55.2866.543+48.743
5Y44.8986.849+38.049
10Y-150.6895.564-156.253
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sarana Meditama Metropolitan is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A PB ratio of 1.42 means the investor is paying Rp1.42 for each Rp1 in book value.

Let's take a look of the Price to Book Ratio trends of Sarana Meditama Metropolitan:

  • The EOD is 1.211. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.419. Based on the equity, the company is underpriced. +1
  • The TTM is 1.419. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.211MRQ1.419-0.208
MRQ1.419TTM1.4190.000
TTM1.419YOY1.431-0.012
TTM1.4195Y4.728-3.309
5Y4.72810Y72.798-68.070
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD1.2111.883-0.672
MRQ1.4192.033-0.614
TTM1.4192.063-0.644
YOY1.4312.286-0.855
5Y4.7282.388+2.340
10Y72.7982.658+70.140
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sarana Meditama Metropolitan compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---47.190-47.1900%226.729-121%30.114-257%21.027-324%
Book Value Per Share--211.387211.3870%258.577-18%127.245+66%80.885+161%
Current Ratio--1.5371.5370%2.594-41%1.764-13%1.307+18%
Debt To Asset Ratio--0.2950.2950%0.104+183%0.430-31%0.458-36%
Debt To Equity Ratio--0.4190.4190%0.135+211%1.041-60%1.046-60%
Dividend Per Share--0.9410.9410%-+100%0.305+208%0.270+249%
Eps--0.2540.2540%8.084-97%-1.170+561%0.863-71%
Free Cash Flow Per Share---4.627-4.6270%6.693-169%-6.838+48%-4.762+3%
Free Cash Flow To Equity Per Share--34.92034.9200%153.443-77%37.572-7%19.115+83%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--40.399--------
Intrinsic Value_10Y_min---79.287--------
Intrinsic Value_1Y_max--1.691--------
Intrinsic Value_1Y_min---7.190--------
Intrinsic Value_3Y_max--6.877--------
Intrinsic Value_3Y_min---22.385--------
Intrinsic Value_5Y_max--14.229--------
Intrinsic Value_5Y_min---38.321--------
Market Cap4387430465536.000-17%5141520076800.0005141520076800.0000%6341208094720.000-19%6073849050726.400-15%22514716416307.199-77%
Net Profit Margin--0.0030.0030%0.109-97%-0.186+6047%-0.042+1455%
Operating Margin--0.0250.0250%0.149-83%0.068-64%0.088-72%
Operating Ratio--1.6341.6340%1.419+15%1.509+8%1.240+32%
Pb Ratio1.211-17%1.4191.4190%1.431-1%4.728-70%72.798-98%
Pe Ratio1009.247-17%1182.7121182.7120%45.767+2484%265.469+346%726.696+63%
Price Per Share256.000-17%300.000300.0000%370.000-19%354.400-15%1313.700-77%
Price To Free Cash Flow Ratio-55.329+15%-64.838-64.8380%55.286-217%44.898-244%-150.689+132%
Price To Total Gains Ratio-5.535+15%-6.487-6.4870%1.632-497%0.785-927%175.809-104%
Quick Ratio--1.3741.3740%2.706-49%1.514-9%1.212+13%
Return On Assets--0.0010.0010%0.028-97%-0.047+5704%0.011-92%
Return On Equity--0.0010.0010%0.036-97%-0.172+14414%-0.004+444%
Total Gains Per Share---46.249-46.2490%226.729-120%30.419-252%21.296-317%
Usd Book Value--362283496.708362283496.7080%443159583.897-18%218076797.925+66%138623585.668+161%
Usd Book Value Change Per Share---0.005-0.0050%0.023-121%0.003-257%0.002-324%
Usd Book Value Per Share--0.0210.0210%0.026-18%0.013+66%0.008+161%
Usd Dividend Per Share--0.0000.0000%-+100%0.000+208%0.000+249%
Usd Eps--0.0000.0000%0.001-97%0.000+561%0.000-71%
Usd Free Cash Flow---7929763.452-7929763.4520%11469920.397-169%-11719046.315+48%-8161914.072+3%
Usd Free Cash Flow Per Share--0.0000.0000%0.001-169%-0.001+48%0.000+3%
Usd Free Cash Flow To Equity Per Share--0.0030.0030%0.015-77%0.004-7%0.002+83%
Usd Market Cap438743046.554-17%514152007.680514152007.6800%634120809.472-19%607384905.073-15%2251471641.631-77%
Usd Price Per Share0.026-17%0.0300.0300%0.037-19%0.035-15%0.131-77%
Usd Profit--434723.084434723.0840%13855385.333-97%-7241300.953+1766%-1139331.973+362%
Usd Revenue--139354215.750139354215.7500%127158406.168+10%93082900.186+50%73307532.215+90%
Usd Total Gains Per Share---0.005-0.0050%0.023-120%0.003-252%0.002-317%
 EOD+4 -4MRQTTM+0 -0YOY+6 -295Y+20 -1510Y+20 -15

3.2. Fundamental Score

Let's check the fundamental score of Sarana Meditama Metropolitan based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-151,009.247
Price to Book Ratio (EOD)Between0-11.211
Net Profit Margin (MRQ)Greater than00.003
Operating Margin (MRQ)Greater than00.025
Quick Ratio (MRQ)Greater than11.374
Current Ratio (MRQ)Greater than11.537
Debt to Asset Ratio (MRQ)Less than10.295
Debt to Equity Ratio (MRQ)Less than10.419
Return on Equity (MRQ)Greater than0.150.001
Return on Assets (MRQ)Greater than0.050.001
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Sarana Meditama Metropolitan based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.503
Ma 20Greater thanMa 50274.800
Ma 50Greater thanMa 100293.720
Ma 100Greater thanMa 200305.940
OpenGreater thanClose258.000
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Minority Interest  13,012-2,51110,501-2,4908,0112,088,6412,096,653-7,332,117-5,235,464



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in IDR. All numbers in thousands.

Summary
Total Assets5,140,003,882
Total Liabilities1,517,168,915
Total Stockholder Equity3,622,834,967
 As reported
Total Liabilities 1,517,168,915
Total Stockholder Equity+ 3,622,834,967
Total Assets = 5,140,003,882

Assets

Total Assets5,140,003,882
Total Current Assets557,972,719
Long-term Assets4,582,031,163
Total Current Assets
Cash And Cash Equivalents 132,136,977
Short-term Investments 12,000,000
Net Receivables 172,424,256
Inventory 40,435,964
Other Current Assets 5,195,774
Total Current Assets  (as reported)557,972,719
Total Current Assets  (calculated)362,192,970
+/- 195,779,749
Long-term Assets
Property Plant Equipment 3,587,167,693
Goodwill 449,245,207
Intangible Assets 75,723,152
Other Assets 130,567,705
Long-term Assets  (as reported)4,582,031,163
Long-term Assets  (calculated)4,242,703,757
+/- 339,327,407

Liabilities & Shareholders' Equity

Total Current Liabilities362,960,921
Long-term Liabilities794,024,981
Total Stockholder Equity3,622,834,967
Total Current Liabilities
Short Long Term Debt 89,404,894
Accounts payable 133,174,152
Other Current Liabilities 36,465,065
Total Current Liabilities  (as reported)362,960,921
Total Current Liabilities  (calculated)259,044,110
+/- 103,916,810
Long-term Liabilities
Long term Debt Total 648,318,137
Other Liabilities 145,706,844
Long-term Liabilities  (as reported)794,024,981
Long-term Liabilities  (calculated)794,024,981
+/- 0
Total Stockholder Equity
Common Stock342,592,651
Retained Earnings -137,994,828
Capital Surplus 3,103,613,269
Other Stockholders Equity 314,623,875
Total Stockholder Equity (as reported)3,622,834,967
Total Stockholder Equity (calculated)3,622,834,967
+/- 0
Other
Capital Stock342,592,651
Cash And Equivalents170,000,000
Cash and Short Term Investments 314,136,977
Common Stock Shares Outstanding 17,129,633
Liabilities and Stockholders Equity 5,140,003,882
Net Debt 431,455,810
Net Invested Capital 4,356,427,754
Net Tangible Assets 3,173,589,760
Net Working Capital 195,011,798
Property Plant and Equipment Gross 4,813,823,451



Balance Sheet

Currency in IDR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
> Total Assets 
324,706,602
320,380,749
302,855,173
290,779,044
377,654,880
466,660,463
1,203,219,994
1,451,906,798
1,714,734,766
2,529,031,900
2,232,894,462
1,889,591,124
4,948,651,095
5,140,003,882
5,140,003,8824,948,651,0951,889,591,1242,232,894,4622,529,031,9001,714,734,7661,451,906,7981,203,219,994466,660,463377,654,880290,779,044302,855,173320,380,749324,706,602
   > Total Current Assets 
0
0
0
0
0
0
245,387,254
120,332,972
203,623,160
427,198,443
116,348,539
245,420,403
859,320,419
557,972,719
557,972,719859,320,419245,420,403116,348,539427,198,443203,623,160120,332,972245,387,254000000
       Cash And Cash Equivalents 
8,527,096
9,401,399
8,807,694
5,685,231
15,292,049
38,918,428
122,260,529
46,117,474
64,341,353
102,860,527
22,702,166
26,174,778
625,070,324
132,136,977
132,136,977625,070,32426,174,77822,702,166102,860,52764,341,35346,117,474122,260,52938,918,42815,292,0495,685,2318,807,6949,401,3998,527,096
       Short-term Investments 
0
0
0
0
0
0
30,000,000
30,000,000
50,000,000
20,000,000
0
0
110,000,000
12,000,000
12,000,000110,000,0000020,000,00050,000,00030,000,00030,000,000000000
       Net Receivables 
16,181,411
20,084,561
21,441,454
21,612,576
16,905,696
25,917,111
52,670,927
50,607,867
112,119,350
200,121,315
71,484,727
129,245,063
161,299,722
172,424,256
172,424,256161,299,722129,245,06371,484,727200,121,315112,119,35050,607,86752,670,92725,917,11116,905,69621,612,57621,441,45420,084,56116,181,411
       Other Current Assets 
3,260,268
2,225,859
4,239,501
2,549,211
3,074,213
44,910,025
53,943,158
4,606,519
4,647,602
85,810,762
3,264,150
8,167,823
5,070,162
5,195,774
5,195,7745,070,1628,167,8233,264,15085,810,7624,647,6024,606,51953,943,15844,910,0253,074,2132,549,2114,239,5012,225,8593,260,268
   > Long-term Assets 
0
0
0
0
0
0
0
1,331,573,826
1,511,111,606
2,101,833,457
2,116,545,923
1,758,244,145
4,089,330,677
4,582,031,163
4,582,031,1634,089,330,6771,758,244,1452,116,545,9232,101,833,4571,511,111,6061,331,573,8260000000
       Property Plant Equipment 
282,406,638
267,631,774
257,319,315
245,029,668
315,102,234
332,014,432
922,942,934
1,315,737,963
1,503,004,686
2,087,039,959
2,060,361,376
1,727,388,521
3,574,919,246
3,587,167,693
3,587,167,6933,574,919,2461,727,388,5212,060,361,3762,087,039,9591,503,004,6861,315,737,963922,942,934332,014,432315,102,234245,029,668257,319,315267,631,774282,406,638
       Goodwill 
0
0
0
0
0
0
0
0
0
0
169,171,868
169,171,868
449,245,207
449,245,207
449,245,207449,245,207169,171,868169,171,8680000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
590,492
14,516,573
75,723,152
75,723,15214,516,573590,49200000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
7,030,810
1,511,111,606
2,101,833,457
2,116,545,923
7,898,109
559,712
738,038
738,038559,7127,898,1092,116,545,9232,101,833,4571,511,111,6067,030,8100000000
> Total Liabilities 
291,704,538
312,238,304
306,901,088
271,555,661
244,644,204
275,581,540
462,047,610
600,934,070
672,450,807
1,202,941,258
1,255,391,516
1,343,775,622
517,055,256
1,517,168,915
1,517,168,915517,055,2561,343,775,6221,255,391,5161,202,941,258672,450,807600,934,070462,047,610275,581,540244,644,204271,555,661306,901,088312,238,304291,704,538
   > Total Current Liabilities 
86,725,346
123,298,954
145,353,073
133,508,542
119,206,075
82,212,290
116,774,002
131,539,666
165,073,723
121,409,442
225,981,134
374,276,638
331,266,656
362,960,921
362,960,921331,266,656374,276,638225,981,134121,409,442165,073,723131,539,666116,774,00282,212,290119,206,075133,508,542145,353,073123,298,95486,725,346
       Short-term Debt 
0
0
0
0
0
0
46,698,891
23,358,556
68,054,131
40,733,866
76,675,831
60,000,000
9,057,597
0
09,057,59760,000,00076,675,83140,733,86668,054,13123,358,55646,698,891000000
       Short Long Term Debt 
0
0
0
0
0
0
46,698,891
23,358,556
71,974,378
45,998,211
85,161,956
67,168,708
15,493,255
89,404,894
89,404,89415,493,25567,168,70885,161,95645,998,21171,974,37823,358,55646,698,891000000
       Accounts payable 
17,788,525
19,160,009
17,837,817
19,144,320
21,696,775
30,576,687
31,568,582
54,366,243
49,575,189
46,902,919
90,913,859
92,999,766
88,014,802
133,174,152
133,174,15288,014,80292,999,76690,913,85946,902,91949,575,18954,366,24331,568,58230,576,68721,696,77519,144,32017,837,81719,160,00917,788,525
       Other Current Liabilities 
14,847,553
15,928,996
23,672,033
23,756,643
23,637,756
38,899,916
27,093,548
42,217,761
33,703,177
19,173,894
34,566,135
67,334,647
70,787,369
36,465,065
36,465,06570,787,36967,334,64734,566,13519,173,89433,703,17742,217,76127,093,54838,899,91623,637,75623,756,64323,672,03315,928,99614,847,553
   > Long-term Liabilities 
0
0
0
0
0
0
0
469,394,404
507,377,084
1,081,531,816
1,029,410,382
1,050,485,726
185,788,600
794,024,981
794,024,981185,788,6001,050,485,7261,029,410,3821,081,531,816507,377,084469,394,4040000000
       Long term Debt Total 
0
0
0
0
0
0
315,302,129
435,931,333
441,055,252
979,123,075
980,103,975
1,011,639,895
20,937,474
648,318,137
648,318,13720,937,4741,011,639,895980,103,975979,123,075441,055,252435,931,333315,302,129000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
-46,698,891
-23,358,556
-68,054,131
-40,733,866
-76,675,831
-59,853,200
7,671,205
8,983,991
8,983,9917,671,205-59,853,200-76,675,831-40,733,866-68,054,131-23,358,556-46,698,891000000
> Total Stockholder Equity
33,002,064
8,142,445
0
19,223,715
133,008,818
191,076,841
741,172,384
850,964,307
1,042,272,494
1,326,077,631
977,492,445
545,815,502
3,836,850,988
3,622,834,967
3,622,834,9673,836,850,988545,815,502977,492,4451,326,077,6311,042,272,494850,964,307741,172,384191,076,841133,008,81819,223,71508,142,44533,002,064
   Retained Earnings 
0
0
0
0
223,365
58,291,388
109,683,245
119,368,881
185,159,987
240,041,060
130,938,265
-291,461,595
-152,907,742
-137,994,828
-137,994,828-152,907,742-291,461,595130,938,265240,041,060185,159,987119,368,881109,683,24558,291,388223,3650000
   Accumulated Other Comprehensive Income 00000000000000
   Capital Surplus 
0
0
0
0
0
0
14,785,453
15,492,043
15,492,043
15,492,043
15,492,043
15,492,043
3,103,614,633
3,103,613,269
3,103,613,2693,103,614,63315,492,04315,492,04315,492,04315,492,04315,492,04314,785,453000000
   Treasury Stock00000000000000



Balance Sheet

Currency in IDR. All numbers in thousands.




Cash Flow

Currency in IDR. All numbers in thousands.




Income Statement

Currency in IDR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,507,499,214
Cost of Revenue-965,727,162
Gross Profit541,772,052541,772,052
 
Operating Income (+$)
Gross Profit541,772,052
Operating Expense-1,451,923,635
Operating Income55,575,578-910,151,583
 
Operating Expense (+$)
Research Development-
Selling General Administrative140,224,734
Selling And Marketing Expenses-
Operating Expense1,451,923,635140,224,734
 
Net Interest Income (+$)
Interest Income6,618,834
Interest Expense-70,175,801
Other Finance Cost-0
Net Interest Income-63,556,967
 
Pretax Income (+$)
Operating Income55,575,578
Net Interest Income-63,556,967
Other Non-Operating Income Expenses-
Income Before Tax (EBT)26,120,66455,575,578
EBIT - interestExpense = -70,175,801
20,604,639
90,780,440
Interest Expense70,175,801
Earnings Before Interest and Taxes (EBIT)-96,296,464
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax26,120,664
Tax Provision-476,618
Net Income From Continuing Ops25,644,04625,644,046
Net Income20,604,639
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-63,556,967
 

Technical Analysis of Sarana Meditama Metropolitan
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sarana Meditama Metropolitan. The general trend of Sarana Meditama Metropolitan is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sarana Meditama Metropolitan's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sarana Meditama Metropolitan.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 266.00 < 282.00 < 284.00.

The bearish price targets are: 242.00 > 242.00 > 242.00.

Tweet this
Sarana Meditama Metropolitan Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sarana Meditama Metropolitan. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sarana Meditama Metropolitan Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sarana Meditama Metropolitan. The current macd is -11.22359063.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sarana Meditama Metropolitan price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Sarana Meditama Metropolitan. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Sarana Meditama Metropolitan price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Sarana Meditama Metropolitan Daily Moving Average Convergence/Divergence (MACD) ChartSarana Meditama Metropolitan Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sarana Meditama Metropolitan. The current adx is 35.61.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Sarana Meditama Metropolitan shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Sarana Meditama Metropolitan Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sarana Meditama Metropolitan. The current sar is 274.06.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Sarana Meditama Metropolitan Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sarana Meditama Metropolitan. The current rsi is 25.50. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Sarana Meditama Metropolitan Daily Relative Strength Index (RSI) ChartSarana Meditama Metropolitan Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sarana Meditama Metropolitan. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sarana Meditama Metropolitan price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Sarana Meditama Metropolitan Daily Stochastic Oscillator ChartSarana Meditama Metropolitan Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sarana Meditama Metropolitan. The current cci is -117.33180209.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Sarana Meditama Metropolitan Daily Commodity Channel Index (CCI) ChartSarana Meditama Metropolitan Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sarana Meditama Metropolitan. The current cmo is -62.87405981.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Sarana Meditama Metropolitan Daily Chande Momentum Oscillator (CMO) ChartSarana Meditama Metropolitan Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sarana Meditama Metropolitan. The current willr is -85.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Sarana Meditama Metropolitan Daily Williams %R ChartSarana Meditama Metropolitan Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sarana Meditama Metropolitan.

Sarana Meditama Metropolitan Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sarana Meditama Metropolitan. The current atr is 12.44.

Sarana Meditama Metropolitan Daily Average True Range (ATR) ChartSarana Meditama Metropolitan Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sarana Meditama Metropolitan. The current obv is 364,606,998.

Sarana Meditama Metropolitan Daily On-Balance Volume (OBV) ChartSarana Meditama Metropolitan Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sarana Meditama Metropolitan. The current mfi is 5.79527567.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Sarana Meditama Metropolitan Daily Money Flow Index (MFI) ChartSarana Meditama Metropolitan Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sarana Meditama Metropolitan.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Sarana Meditama Metropolitan Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sarana Meditama Metropolitan based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.503
Ma 20Greater thanMa 50274.800
Ma 50Greater thanMa 100293.720
Ma 100Greater thanMa 200305.940
OpenGreater thanClose258.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sarana Meditama Metropolitan with someone you think should read this too:
  • Are you bullish or bearish on Sarana Meditama Metropolitan? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sarana Meditama Metropolitan? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sarana Meditama Metropolitan

I send you an email if I find something interesting about Sarana Meditama Metropolitan.


Comments

How you think about this?

Leave a comment

Stay informed about Sarana Meditama Metropolitan.

Receive notifications about Sarana Meditama Metropolitan in your mailbox!